regulatory
confidence high
sentiment negative
materiality 0.65
Dare Bioscience, Inc. (DARE): Nasdaq/NYSE listing notice — Daré Bioscience receives Nasdaq deficiency notice for bid price below $1.00; has until Jan 16, 2024 to regain compliance
Dare Bioscience, Inc.
- Received Nasdaq letter on July 19, 2023, for failing Minimum Bid Price Requirement over 30 consecutive business days.
- Has 180 calendar days (until Jan 16, 2024) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not, may be eligible for additional 180-day period if meeting other listing standards.
- Cannot assure compliance; considering options including reverse stock split.